Literature DB >> 9808768

Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.

K Ahn1, S B Herman, D C Fahnoe.   

Abstract

Endothelin-converting enzyme-1 (ECE-1) is a type II integral membrane protein that belongs to a family of metalloproteases which includes ECE-2, neprilysin (neutral endopeptidase 24.11, EC 3.4.24. 11), and Kell blood group protein. ECE-1 cleaves its biologically inactive native substrate, big endothelin-1, to generate a powerful vasoactive 21-amino acid peptide, endothelin-1. ECE-1 consists of a short N-terminal cytoplasmic tail, a transmembrane hydrophobic domain, and a large extracellular domain containing the catalytic site with a conserved Zn-binding motif. We have constructed a secreted, soluble form of ECE-1 (solECE-1) by fusing the cleavable N-terminal signal sequence of human alkaline phosphatase in frame with the entire extracellular domain of ECE-1. Stable transfectant CHO cell lines expressing up to 6.1 mg of solECE-1 per liter culture medium were established and solECE-1 was purified to homogeneity using three chromatographic steps with a 24% yield. SolECE-1 behaves as a dimer of 110-kDa subunits. SolECE-1 has a sharp pH optimum, similar to the native form, ECE-1a, but has a slightly more acidic pH optimum of 6.1-6.4 than that of 6.7-6.9 for ECE-1a. At its optimal pH of 6.4, solECE-1 cleaved big ET-1:big ET-2:big ET-3 in a ratio of 8.1:1:1.4, was inhibited by phosphoramidon with an IC50 value of 0.35 +/- 0.05 microM, had a Km value of 4.65 +/- 0.78 microM for big ET-1, and had a kcat value of 5.82 +/- 0.21 min-1, all values comparable to those for ECE-1a at its optimal pH of 6.8. Phosphoramidon inhibition of both ECE-1a and solECE-1 is highly pH-dependent. At pH 5.8, phosphoramidon inhibited ECE-1a and solECE-1 with IC50 values of 14 and 33 nM, respectively, which are 49- and 1224-fold more potent than at pH 7.2. SolECE-1 is highly glycosylated, similar to ECE-1a. Deglycosylation of solECE-1 by peptide N-glycosidase F shifted the apparent molecular weight of solECE-1 to approximately 80 kDa and the deglycosylated form(s) of solECE-1 preserved at least 72% of the activity of the glycosylated form. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808768     DOI: 10.1006/abbi.1998.0913

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Secretion of endothelin converting enzyme-1a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization.

Authors:  S C Brooks; L Fernandez; A Ergul
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay.

Authors:  Tanja Ouimet; Sou-Vinh Orng; Hervé Poras; Khatuna Gagnidze; Lakshmi A Devi; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.

Authors:  Suqing Wang; Rui Wang; Lang Chen; David A Bennett; Dennis W Dickson; Deng-Shun Wang
Journal:  J Neurochem       Date:  2010-07-30       Impact factor: 5.372

4.  Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.

Authors:  Rui Wang; Suqing Wang; James S Malter; Deng-Shun Wang
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

5.  Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Authors:  R M Fryer; J Segreti; P N Banfor; D L Widomski; B J Backes; C W Lin; S J Ballaron; B F Cox; J M Trevillyan; G A Reinhart; T W von Geldern
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

6.  CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo.

Authors:  Ishminder K Mann; Raghunath Chatterjee; Jianfei Zhao; Ximiao He; Matthew T Weirauch; Timothy R Hughes; Charles Vinson
Journal:  Genome Res       Date:  2013-04-16       Impact factor: 9.043

Review 7.  Neprilysin Inhibitors and Bradykinin.

Authors:  Duncan J Campbell
Journal:  Front Med (Lausanne)       Date:  2018-09-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.